IL326602A - מאפנני פירידיל אמין שלישוניים לביוסינתיזה של כולסטרול ושימושים בהם לקידום רמילינציה - Google Patents
מאפנני פירידיל אמין שלישוניים לביוסינתיזה של כולסטרול ושימושים בהם לקידום רמילינציהInfo
- Publication number
- IL326602A IL326602A IL326602A IL32660226A IL326602A IL 326602 A IL326602 A IL 326602A IL 326602 A IL326602 A IL 326602A IL 32660226 A IL32660226 A IL 32660226A IL 326602 A IL326602 A IL 326602A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- pharmaceutically acceptable
- solvate
- acceptable salt
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363579221P | 2023-08-28 | 2023-08-28 | |
| PCT/US2024/044067 WO2025049495A1 (en) | 2023-08-28 | 2024-08-27 | Tertiary pyridyl amine modulators of cholesterol biosynthesis and their use for promoting remylination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326602A true IL326602A (he) | 2026-04-01 |
Family
ID=92800630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326602A IL326602A (he) | 2023-08-28 | 2024-08-27 | מאפנני פירידיל אמין שלישוניים לביוסינתיזה של כולסטרול ושימושים בהם לקידום רמילינציה |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4770996A1 (he) |
| KR (1) | KR20260060355A (he) |
| CN (1) | CN121752546A (he) |
| AU (1) | AU2024334493A1 (he) |
| IL (1) | IL326602A (he) |
| MX (1) | MX2026002492A (he) |
| WO (1) | WO2025049495A1 (he) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| WO2021247916A1 (en) * | 2020-06-03 | 2021-12-09 | Yumanity Therapeutics, Inc. | Azetidine and spiroazetidine compounds and uses thereof |
| WO2023107547A2 (en) * | 2021-12-08 | 2023-06-15 | Kineta, Inc. | Azetidine and spiroazetidine compounds and uses thereof |
-
2024
- 2024-08-27 WO PCT/US2024/044067 patent/WO2025049495A1/en not_active Ceased
- 2024-08-27 EP EP24772493.3A patent/EP4770996A1/en active Pending
- 2024-08-27 KR KR1020267008757A patent/KR20260060355A/ko active Pending
- 2024-08-27 IL IL326602A patent/IL326602A/he unknown
- 2024-08-27 CN CN202480055163.1A patent/CN121752546A/zh active Pending
- 2024-08-27 AU AU2024334493A patent/AU2024334493A1/en active Pending
-
2026
- 2026-02-27 MX MX2026002492A patent/MX2026002492A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN121752546A (zh) | 2026-03-27 |
| MX2026002492A (es) | 2026-04-01 |
| KR20260060355A (ko) | 2026-05-04 |
| EP4770996A1 (en) | 2026-07-08 |
| WO2025049495A1 (en) | 2025-03-06 |
| AU2024334493A1 (en) | 2026-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021377211A9 (en) | Apparatus for delivering enhanced stimulation waveforms | |
| IL321027A (he) | מאפננים של פעילות tnf-אלפא | |
| EP4038450A4 (en) | ELECTRO-OPTICAL ELEMENTS AND FORMATION METHOD | |
| GB2588305B (en) | Apparatus of shaking compensation and method of shaking compensation | |
| EP4061349A4 (en) | CORONAVIRUS TREATMENT METHODS | |
| EP4203342A4 (en) | FREQUENCY COMPENSATION METHOD AND FREQUENCY COMPENSATION APPARATUS | |
| EP4332264A4 (en) | NON-ORIENTED SILICON STEEL AND PRODUCTION PROCESS THEREOF | |
| IL317543A (he) | מודולטורים של קינאז ושיטות לשימוש בהם | |
| EP4274463A4 (en) | METHODS AND DEVICES FOR EXTRACOCHLEAR STIMULATION | |
| CA3299242A1 (en) | Tertiary pyridyl amine modulators of cholesterol biosynthesis and their use for promoting remylination | |
| EP4045644A4 (en) | COMPOSITIONS AND METHODS OF USING ALTERNATIVE SPLICING TO REGULATE GENE THERAPY SPECIFICITY | |
| EP3886353A4 (en) | RELAY DEVICE TIME SYNCHRONIZATION APPARATUS AND METHOD THEREOF | |
| GB2623894B (en) | Ophthalmic apparatus and method of alignment of ophthalmic apparatus | |
| IL325591A (he) | צורה גבישית של בקסדרוסטאט ושיטה להכנתו ושימוש בו | |
| ZA202101308B (en) | Method and apparatus of music education | |
| IL319624A (he) | מאפנני אזול לביוסינתיזה של כולסטרול והשימוש בהם לקידום יצירה מחדש של מיאלין | |
| CA234388S (en) | Non-audiovisual aid teaching apparatus | |
| IL326072A (he) | צורה גבישית של בזוקלסטיניב, שיטה להכנתה והשימוש בה | |
| HK40131026A (en) | Cd122 binding agents and method of using same | |
| HK40091385A (en) | Il10rb binding molecules and methods of use | |
| CA3268986A1 (en) | Azole modulators of cholesterol biosynthesis and their use for promoting remyelination | |
| AU2021904173A0 (en) | Inhibitors of TBK1 and/or IKKε | |
| ZA202105132B (en) | Teaching aid for teaching mathematics and applied mathematics | |
| ZA202301824B (en) | Application of bacillus velezensis | |
| PL4163211T3 (pl) | Sposób montażu zestawów wyrobów sanitarnych i związana z nim aparatura |